Mirexus Biotechnologies secures $3.7 mln in Series A funding
Canadian biotechnology startup Mirexus Biotechnologies Inc has obtained US$3.7 million in a Series A financing. The round was led by Barbados-based Goddard Enterprises Ltd and was joined by investors associated with the GreenSky Presidents Club, which helped to seed the company in 2014. Proceeds of the investment will be used by Mirexus to market its products, to build manufacturing capability, and to enhance its research capability. Based in Guelph, Ontario, the company is commercializing a novel nanotechnology based on polysaccharide nanoparticles that can be used in a range of markets, from cosmetics to nutraceuticals to biomedical applications.
4 May 2015•4 mins read
